|
WO2021080920A2
|
|
Combination therapy for the treatment of solid and hematological cancers
|
|
WO2021046216A1
|
|
Methods for identifying biomarkers to predict treatment response
|
|
WO2020232427A2
|
|
Therapeutic compositions and methods for treating cancer in combination with analogs of interleukin proteins
|
|
WO2020198370A2
|
|
Therapeutic cd47 antibodies
|
|
WO2020102422A1
|
|
THERAPEUTIC SIRPα ANTIBODIES
|
|
WO2020097564A1
|
|
Biomarkers to improve efficacy of cancer immunotherapy
|
|
WO2020036977A1
|
|
Therapeutic cd47 antibodies
|
|
US2019309066A1
|
|
Combination therapy for the treatment of solid and hematological cancers
|
|
WO2018175790A1
|
|
Combination therapy for the treatment of solid and hematological cancers
|
|
EP3529276A1
|
|
Therapeutic cd47 antibodies
|
|
AU2016324316A1
|
|
Therapeutic CD47 antibodies
|
